Using Nutraceuticals to Help Manage Traumatic Spinal Cord Injury

Traumatic spinal cord injury (TSCI) is a significant public health challenge that has an adverse impact on functional independence, quality of life, and life expectancy. Management of people’s chronic conditions is a key aspect of contemporary medical practice. Our study was an open label, single ar...

Full description

Bibliographic Details
Main Authors: Paul Stacey, Arun Mensinkai, Pankaj Bansal, Seyed-Hossein Hosseini, Andrew Lavigne, Basia Gwardjan, Sayna Leylachian, Zhihui (Joy) Deng, Vinjamuri Chari, Sandra Giles, Shanker Nesathurai
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Pharmaceuticals
Subjects:
Online Access:https://www.mdpi.com/1424-8247/17/1/71
_version_ 1797342819639099392
author Paul Stacey
Arun Mensinkai
Pankaj Bansal
Seyed-Hossein Hosseini
Andrew Lavigne
Basia Gwardjan
Sayna Leylachian
Zhihui (Joy) Deng
Vinjamuri Chari
Sandra Giles
Shanker Nesathurai
author_facet Paul Stacey
Arun Mensinkai
Pankaj Bansal
Seyed-Hossein Hosseini
Andrew Lavigne
Basia Gwardjan
Sayna Leylachian
Zhihui (Joy) Deng
Vinjamuri Chari
Sandra Giles
Shanker Nesathurai
author_sort Paul Stacey
collection DOAJ
description Traumatic spinal cord injury (TSCI) is a significant public health challenge that has an adverse impact on functional independence, quality of life, and life expectancy. Management of people’s chronic conditions is a key aspect of contemporary medical practice. Our study was an open label, single arm, prospective pilot study to evaluate the feasibility of treating people with TSCI. The study intervention was treatment with oral selenium and vitamin E. Participants were 18 years or older and experienced a TSCI at least one year prior to enrollment. Daily doses of 50 mcg of selenium and 400 IU of vitamin E were administered. Participants had radiologic (MRI tractography) and clinical (ASIA) assessments prior to initiating treatment, and these assessments were repeated after one year of treatment. Four subjects completed the full twelve-month study. Adherence, based on pill counts, was approximately 75% in all subjects. There were no adverse events related to study medications. During the treatment period, subjects reported improvement in certain symptoms. There was no significant difference in ASIA scores before and after the intervention. Combination treatment with vitamin E and selenium has been demonstrated as safe for TSCI patients. It is possible to use DTI values to locate the epicenter of a lesion as well as gauge the extent of injury. MRI tractography may serve as a meaningful surrogate endpoint. The results of this study suggest that it is feasible to conduct a larger long-term clinical trial to evaluate the efficacy of combination treatment of TSCI.
first_indexed 2024-03-08T10:38:42Z
format Article
id doaj.art-add6c71d77fd48dfb9c4abc77ab26b8c
institution Directory Open Access Journal
issn 1424-8247
language English
last_indexed 2024-03-08T10:38:42Z
publishDate 2024-01-01
publisher MDPI AG
record_format Article
series Pharmaceuticals
spelling doaj.art-add6c71d77fd48dfb9c4abc77ab26b8c2024-01-26T18:05:42ZengMDPI AGPharmaceuticals1424-82472024-01-011717110.3390/ph17010071Using Nutraceuticals to Help Manage Traumatic Spinal Cord InjuryPaul Stacey0Arun Mensinkai1Pankaj Bansal2Seyed-Hossein Hosseini3Andrew Lavigne4Basia Gwardjan5Sayna Leylachian6Zhihui (Joy) Deng7Vinjamuri Chari8Sandra Giles9Shanker Nesathurai10Department of Physical Medicine and Rehabilitation, Hamilton Health Sciences, Hamilton, ON L8L 2X2, CanadaDepartment of Diagnostic Imaging, Hamilton Health Sciences, Hamilton, ON L8L 2X2, CanadaDepartment of Physical Medicine and Rehabilitation, Hamilton Health Sciences, Hamilton, ON L8L 2X2, CanadaDepartment of Physical Medicine and Rehabilitation, Hamilton Health Sciences, Hamilton, ON L8L 2X2, CanadaDepartment of Physical Medicine and Rehabilitation, Hamilton Health Sciences, Hamilton, ON L8L 2X2, CanadaDivision of Physical Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON L8S 4L8, CanadaDivision of Physical Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON L8S 4L8, CanadaDepartment of Physical Medicine and Rehabilitation, Hamilton Health Sciences, Hamilton, ON L8L 2X2, CanadaDepartment of Physical Medicine and Rehabilitation, Hamilton Health Sciences, Hamilton, ON L8L 2X2, CanadaDepartment of Medical Imaging, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON L8S 4L8, CanadaDepartment of Physical Medicine and Rehabilitation, Hamilton Health Sciences, Hamilton, ON L8L 2X2, CanadaTraumatic spinal cord injury (TSCI) is a significant public health challenge that has an adverse impact on functional independence, quality of life, and life expectancy. Management of people’s chronic conditions is a key aspect of contemporary medical practice. Our study was an open label, single arm, prospective pilot study to evaluate the feasibility of treating people with TSCI. The study intervention was treatment with oral selenium and vitamin E. Participants were 18 years or older and experienced a TSCI at least one year prior to enrollment. Daily doses of 50 mcg of selenium and 400 IU of vitamin E were administered. Participants had radiologic (MRI tractography) and clinical (ASIA) assessments prior to initiating treatment, and these assessments were repeated after one year of treatment. Four subjects completed the full twelve-month study. Adherence, based on pill counts, was approximately 75% in all subjects. There were no adverse events related to study medications. During the treatment period, subjects reported improvement in certain symptoms. There was no significant difference in ASIA scores before and after the intervention. Combination treatment with vitamin E and selenium has been demonstrated as safe for TSCI patients. It is possible to use DTI values to locate the epicenter of a lesion as well as gauge the extent of injury. MRI tractography may serve as a meaningful surrogate endpoint. The results of this study suggest that it is feasible to conduct a larger long-term clinical trial to evaluate the efficacy of combination treatment of TSCI.https://www.mdpi.com/1424-8247/17/1/71spinal cord injurynutraceuticalstractographyvitamin Eselenium
spellingShingle Paul Stacey
Arun Mensinkai
Pankaj Bansal
Seyed-Hossein Hosseini
Andrew Lavigne
Basia Gwardjan
Sayna Leylachian
Zhihui (Joy) Deng
Vinjamuri Chari
Sandra Giles
Shanker Nesathurai
Using Nutraceuticals to Help Manage Traumatic Spinal Cord Injury
Pharmaceuticals
spinal cord injury
nutraceuticals
tractography
vitamin E
selenium
title Using Nutraceuticals to Help Manage Traumatic Spinal Cord Injury
title_full Using Nutraceuticals to Help Manage Traumatic Spinal Cord Injury
title_fullStr Using Nutraceuticals to Help Manage Traumatic Spinal Cord Injury
title_full_unstemmed Using Nutraceuticals to Help Manage Traumatic Spinal Cord Injury
title_short Using Nutraceuticals to Help Manage Traumatic Spinal Cord Injury
title_sort using nutraceuticals to help manage traumatic spinal cord injury
topic spinal cord injury
nutraceuticals
tractography
vitamin E
selenium
url https://www.mdpi.com/1424-8247/17/1/71
work_keys_str_mv AT paulstacey usingnutraceuticalstohelpmanagetraumaticspinalcordinjury
AT arunmensinkai usingnutraceuticalstohelpmanagetraumaticspinalcordinjury
AT pankajbansal usingnutraceuticalstohelpmanagetraumaticspinalcordinjury
AT seyedhosseinhosseini usingnutraceuticalstohelpmanagetraumaticspinalcordinjury
AT andrewlavigne usingnutraceuticalstohelpmanagetraumaticspinalcordinjury
AT basiagwardjan usingnutraceuticalstohelpmanagetraumaticspinalcordinjury
AT saynaleylachian usingnutraceuticalstohelpmanagetraumaticspinalcordinjury
AT zhihuijoydeng usingnutraceuticalstohelpmanagetraumaticspinalcordinjury
AT vinjamurichari usingnutraceuticalstohelpmanagetraumaticspinalcordinjury
AT sandragiles usingnutraceuticalstohelpmanagetraumaticspinalcordinjury
AT shankernesathurai usingnutraceuticalstohelpmanagetraumaticspinalcordinjury